myelosuppressive therapy

myelosuppressive therapy

Oncology Any therapy intended to inhibit or frankly wipe out normal cell proliferation in the BM. Cf Myelosuppression.

Myelosuppressive therapy

Any form of treatment that is aimed at slowing down the rate of blood cell production.
Mentioned in: Polycythemia Vera
References in periodicals archive ?
A randomized, non-inferiority study of recombinant human G-CSF/human serum albumin fusion (CG-10639) and pegfilgrastim in breast cancer patients receiving myelosuppressive therapy.
ESAs are not indicated for patients receiving myelosuppressive therapy when the anticipated outcome is cure.
Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
ESAs are not indicated for cancer patients receiving myelosuppressive therapy when the anticipated outcome of such therapy is cure.
Neutropenia increases the risk of infection and often results in dose reduction or delayed delivery of myelosuppressive therapy, thereby compromising treatment outcome.